Clinical Rheumatology

Papers
(The H4-Index of Clinical Rheumatology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment555
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets188
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad169
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series93
COVID-19 and the clinical course of rheumatic manifestations79
Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?78
High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia76
Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology74
Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months73
Post-COVID-19 arthritis: a case report and literature review70
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease69
YouTube as a source of information on COVID-19 and rheumatic disease link67
Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India65
High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review62
Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis53
Haemophagocytic syndrome and COVID-1950
Ankylosing spondylitis risk factors: a systematic literature review47
Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment46
Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis45
COVID-19 vaccination in immunocompromised patients44
Long COVID from rheumatology perspective — a narrative review42
Rheumatoid arthritis–associated interstitial lung disease: an overview of epidemiology, pathogenesis and management42
Managing rheumatoid arthritis during COVID-1941
Gout: a disease involved with complicated immunoinflammatory responses: a narrative review41
COVID-19 with rheumatic diseases: a report of 5 cases40
The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study39
Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus37
Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis37
The usefulness and validity of English-language videos on YouTube as an educational resource for spondyloarthritis37
Moving towards online rheumatology education in the era of COVID-1936
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab35
Colchicine may not be effective in COVID-19 infection; it may even be harmful?35
Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still’s disease34
Treatment algorithm for COVID-19: a multidisciplinary point of view34
Colchicine as a possible therapeutic option in COVID-19 infection34
0.12485289573669